Managed Care and Corporate Medical Directors Webinars: Use of Biomarker and Molecular Testing and Review of the NCCN Biomarkers Compendium™

February 22, 2013

This educational program is designed specifically to address the interests of managed care and corporate medical directors. Each webinar will feature a different topic based on feedback from a sample of medical directors along with an interactive question and answer period for participants. NCCN offers continuing education credits for physicians (CME) for these webinars.

Target Audience

This activity is designed to meet the educational needs of health plan medical directors.

Learning Objectives

Following this activity, participants should be able to:

  • Describe the criteria used by NCCN to include a biomarker test in the NCCN Guidelines and Biomarkers Compendium
  • Articulate examples of biomarker tests with demonstrated efficacy
Additional information
Supporters: 

This activity is supported by educational grants from Astellas; Celgene Corporation; Lilly USA, LLC; and Pfizer.

Course summary
Available credit: 
  • 0.75 Participation
  • 0.75 Physician
Course opens: 
02/22/2013
Course expires: 
05/01/2013
Event starts: 
02/22/2013 - 12:45pm
Event ends: 
02/22/2013 - 1:30pm
Cost:
$0.00

Phillip Febbo, MD
Associate Professor, Department of Medicine (Hematology/Oncology)
UCSF Helen Diller Family Comprehensive Cancer Center

Available Credit

  • 0.75 Participation
  • 0.75 Physician

Accreditation Period

Course opens: 
02/22/2013
Course expires: 
05/01/2013

Price

Cost:
$0.00
Please login or register to take this course.